Recovering Losses from Crocs, Inc. Investment New York, NY / Access Newswire / January 26, 2025 If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, you are not alone. Many investors find themselves in a similar situation, facing unexpected losses…
Suffered a Loss on Your Five9, Inc. (NASDAQ:FIVN) Investment? Potential Recovery Under Federal Securities Laws Have you experienced a financial loss on your investment in Five9, Inc. (NASDAQ:FIVN)? If so, you may be eligible to seek recovery under the federal securities laws. To find out more information about your potential options, visit the link below…
Seeking Recovery for Losses on Applied Therapeutics, Inc. Investment Introduction Have you suffered a loss on your investment in Applied Therapeutics, Inc. (NASDAQ:APLT)? If so, you may be entitled to seek recovery under the federal securities laws. It’s important to stay informed about your rights as an investor and take action if you believe you…
Breaking News: Class Action Lawsuit Filed Against BioAge Labs, Inc. What’s Going On? Well, folks, it looks like BioAge Labs, Inc. is in some hot water. Pomerantz LLP has announced that a class action lawsuit has been filed against the company. That’s right, BioAge is facing some legal troubles and investors are advised to take…
Welcome to the Jungle: A Wild Investigation into Franklin Resources, INC. The Setting: New York, NY / ACCESS Newswire / January 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Franklin Resources, INC. (“Franklin” or the “Company”) (NYSE:BEN) The Plot Thickens: Well folks, it looks like we’ve got ourselves a good…
Welcome to the Construction Zone: A Rollercoaster Ride for Investors Hold on to your hard hats, folks! Pomerantz LLP is on the case. Hey there, investors! If you’ve got your money in Construction Partners, Inc. (NASDAQ:ROAD), you might want to pay attention to this. Pomerantz LLP is currently looking into some claims that could shake…
Class Action Lawsuit Filed Against Kyverna Therapeutics, Inc. New York City, NY / ACCESS Newswire / January 26, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQ:KYTX). Investors who have purchased shares of Kyverna Therapeutics, Inc. are advised to contact Danielle Peyton…
Welcome to the Pomerantz LLP Blog! Pomerantz LLP Investigating Claims Against Sangamo Therapeutics, Inc. January 26, 2025 Here at Pomerantz LLP, we take pride in representing investors in cases of corporate misconduct and securities fraud. Currently, we are investigating claims on behalf of investors of Sangamo Therapeutics, Inc. (“Sangamo” or the “Company”) listed on the…
